Aurobindo Pharma Ltd.

AUROPHARMA Share PricePharmaceuticals & Drugs

1,195.1

22.9 (2%)

As on December 12, 2025

Exchange Scrips: BSE524804NSEAUROPHARMAISININE406A01037

Market Cap69,412 Cr

P/E Ratio 19.91

Dividend Yield N/A

Performance

Market performance

Open1,175.1
High1,199.5
Volumes6,70,100
Prev1,195.1
Low1,170.4
As on2025-12-12

Historical performance

1 Year High1,356.2
3 Year High1,592
5 Year High1,592
1 Year Low1,010
3 Year Low397.2
5 Year Low397.2

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
69,412
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
19.91
Dividend Yield
Dividend Yield
N/A

Investment Returns

1 Year
-1.6%
3 Years
164.8%
5 Years
33.2%
10 Years
47.7%

Technicals

IndicatorsValueSignal
5-DMA1,176.18Bullish
10-DMA1,196.19Bearish
20-DMA1,208.97Bearish
50-DMA1,157.74Bullish
100-DMA1,119.69Bullish
200-DMA1,135.58Bullish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters1414141414
Foreign Investors11111
Domestic Investors1313131313
Public Investors247648272194269309257948248474
Government---1111

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 19.91.
  • 3Y Stock Price CAGR of the stock is 38.1.
  • The stock has a beta of 1.1.
  • In the last financial year, the company had an EBITDA of ₹72046 Million.
  • The company generated revenue of ₹317237 Million in the previous financial year.

Aurobindo Pharma Ltd.

1195.122.9   (2%)

Investment Amount: ₹ 1000000
Current Value: ₹ 988993.7
No. of Shares: 828 (Approx)
Performance:-1.1%
P/L: ₹-11006.3

Top Gainers

SymbolChange%
MAHAPEXLTD95.24(20%)
VIPULLTD10.24(20%)
TVVISION7.77(20%)
TARIL280.2(17%)
WALCHANNAG175.53(14%)

Top Losers

SymbolChange%
REFEX254.9(-20%)
VLSFINANCE299.45(-10%)
BALAXI30.06(-9%)
VLEGOV21.01(-9%)
KSR17.33(-9%)
ASMS12.2(-8%)
VINNY1.28(-7%)
RAJSREESUG37.79(-6%)

Peer Comparison

Venus Remedies Ltd.

53.5%

825.4

1 Month Performance

Nectar Lifesciences Ltd.

48.7%

21.04

1 Month Performance

SMS Pharmaceuticals Ltd.

11.4%

320.7

1 Month Performance

Natco Pharma Ltd.

10.1%

905.65

1 Month Performance

Haleos Labs Ltd.

9.8%

1386.8

1 Month Performance

Ipca Laboratories Ltd.

9.3%

1465.9

1 Month Performance

Zota Health Care Ltd.

9%

1670.2

1 Month Performance

Emcure Pharmaceuticals Ltd.

7.6%

1438.6

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month